016580.KS
Whan In Pharm Co.,Ltd.
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 10,480.00
+3.35%Next report
Analyst consensus
- Next report date
- Mar 18, 2027
- EPS estimate
- —
- Revenue estimate
- KRW 71.9B
Latest reported
- Last report date
- Oct 29, 2026
- EPS actual
- KRW 349
- EPS estimate
- —
- Revenue actual
- KRW 68.8B
- Revenue estimate
- KRW 68.8B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- —
- EPS misses (12Q)
- —
- EPS in line (12Q)
- —
- Avg surprise (4Q)
- —
- Revenue beats (12Q)
- 1
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Oct 29, 2026 | — | KRW 349 | — | KRW 68.8B |
| Jul 29, 2026 | — | KRW 411 | — | KRW 71.4B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Mar 18, 2027